+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Malaysia Eye Drop Market, Competition, Forecast & Opportunities, 2028

  • PDF Icon

    Report

  • 73 Pages
  • October 2023
  • Region: Malaysia
  • TechSci Research
  • ID: 5893609
Free Webex Call
10% Free customization
Free Webex Call

Speak directly to the analyst to clarify any post sales queries you may have.

10% Free customization

This report comes with 10% free customization, enabling you to add data that meets your specific business needs.

The Malaysia eye drop market is anticipated to grow significantly in the projected period of 2028. Malaysia's eye drop market has experienced significant growth in recent years. This can be attributed to an increase in eye-related disorders, increased awareness of eye health, and the introduction of new and advanced eye drop products in the market. Eye drops are liquid drops that are typically applied in small amounts, such as one or a few drops, directly to the surface of the eye. Saline is typically present in eye drops to match the salinity of the eye. Artificial tears, or drops containing only saline and occasionally a lubricant, are frequently used to treat dry eyes or mild eye irritation like itching or redness. Several different eye diseases can be treated with eye drops that also contain one or more medications. Due to the increased demand for eye drops and related products, the Malaysia eye drop market is flourishing. The rising incidence of eye diseases is another factor influencing the expansion of the Malaysian eye drop market. In Malaysia, the prevalence of myopia among children and young adults has increased along with age-related eye diseases. Growing awareness of the significance of eye health is another factor driving growth in the Malaysian eye drop market, in addition to aging population and increase in the prevalence of eye diseases. As people age, the risk of developing eye diseases such as cataracts, glaucoma, and age-related macular degeneration increases. According to the World Bank, in 2020, more than 7% of the population was over 65, which met the standard definition of an "ageing society" used internationally. Malaysia will be an "aged society" by 2044, where 14% of the population is predicted to be over 65 and by 2056. Malaysia will be a "super-aged society" with more than 20% of the population being over 65. Information on eye health and the significance of routine eye exams is more widely available than ever due to the growth of social media and other digital channels. Both domestic and foreign businesses are investing in the Malaysian eye drop market. The Malaysian eye drop market will grow during the forecast period because of several multinational companies entering the market in recent years and bringing with them cutting-edge technologies and products. In addition to the factors mentioned above, the increasing disposable income of the population has also contributed to the growth of the eye drop market in Malaysia. With higher disposable incomes, people are more likely to spend money on eye drops, which is expected to grow the Malaysian eye drop market. The Malaysian government has also been promoting eye health and awareness through various campaigns and initiatives. This has led to an increase in demand for eye drop products, as people are becoming more proactive about taking care of their eye health. The availability of a wide range of eye drops in the market is also driving the growth in this sector. There are many different types of eye drops available in Malaysia, each designed to treat specific conditions. For example, artificial tears are used to treat dry eyes, while antihistamine drops are used to manage allergies. The availability of these products has made it easier for people to manage their eye problems and has contributed to the overall growth of the eye drop market in Malaysia. The rise in demand for eye drops has not gone unnoticed by manufacturers, and many companies are now focusing on developing new products to cater to this growing market. Additionally, advancements in technology have resulted in the development of innovative and effective eye drop products that cater to specific eye conditions, hence augmenting the growth of the Malaysia eye drop market.

Rising Geriatric Population is Expanding the Malaysian Eye Drop Market

The geriatric population in Malaysia is rapidly increasing, and this has led to a rise in the demand for eye drops in the country. Eye drops are used to treat a variety of eye-related problems, such as dry eyes, allergies, and infections. As people age, their eyes become more vulnerable to various diseases, such as cataracts, glaucoma, and macular degeneration. These conditions can cause vision loss and impair quality of life. Eye drops are an effective way to manage these conditions, and they are becoming increasingly popular among the elderly population in Malaysia. Another factor contributing to the rise in demand for eye drops in Malaysia is the increasing prevalence of diabetes. Diabetes can cause a range of eye problems, such as diabetic retinopathy, which can lead to blindness if left untreated. According to the National Health and Morbidity Survey 2019, in Malaysia, type 2 diabetes (T2D) prevalence has increased to 20.8% in persons over the age of 30, affecting 2.8 million people. As the number of diabetics in Malaysia increases, so does the demand for eye drops to manage their eye-related complications. According to the Department of Statistics Malaysia (DoSM), the proportion of Malaysia's population over the age of 65 increased as well, from 5% in 2010 to 6.8% in 2020 and by 2050, more than 15% of Malaysia's population would be over the age of 65.

Rising Prevalence of Eye Diseases is Booming the Malaysia Eye Drop Market

In recent years, Malaysia has seen a rise in the prevalence of eye diseases, with an increasing number of individuals suffering from eye-related problems such as cataracts, glaucoma, dry eye syndrome, and age-related macular degeneration (AMD). This rise in the incidence of eye diseases has led to a corresponding boom in the Malaysia eye drop market as individuals seek out products that can help alleviate their symptoms and maintain good eye health. One of the major drivers of the Malaysia eye drop market is the increasing incidence of cataracts, which is a leading cause of blindness in the country. According to the National Library of Medicines, in 2022, the prevalence of cataract among older people was 26.8%. Glaucoma is another eye disease that is becoming increasingly prevalent in Malaysia. The condition is often referred to as the "silent thief of sight" as it often progresses slowly and without symptoms, until significant vision loss occurs. As a result, early detection and treatment are critical in preventing vision loss from glaucoma, and many individuals turn to eye drops as a first line of defense, leading to the rise I demand for the Malaysia eye drop market. Dry eye syndrome is yet another condition that is on the rise in Malaysia, particularly among those who spend long hours working on computers or smartphones. The condition is characterized by a lack of lubrication on the surface of the eye, which can cause discomfort, redness, and blurred vision. Eye drops containing artificial tears are often used to alleviate these symptoms. Age-related macular degeneration (AMD) is also becoming more prevalent in Malaysia, particularly as the population ages. The condition is a leading cause of vision loss in individuals over the age of 60, and while there is no cure, there are several treatments available, including eye drops that can help slow the progression of the disease. In response to the rising prevalence of eye diseases, the Malaysia eye drop market has become increasingly competitive, with a wide range of products now available to suit different needs, these companies offer a range of eye drops targeting various conditions, including dry eye, glaucoma, and cataracts. The Malaysia eye drop market is highly competitive, with both local and international players competing for market share leading to the growth of the Malaysian eye drop market.

Market Segmentation

Malaysia eye drop market is segmented into type, drug class, disease indication, distribution channel, region, and company. Based on type, Malaysia eye drop market is divided into prescription and over the counter. Based on drug class, Malaysia eye drop market is categorized into antiallergy, anti-inflammatory, antiglaucoma, anti-VEGF, and others. Based on disease indication, Malaysia eye drop market is categorized into dry eye diseases, glaucoma, eye allergy, eye infections, retinal disorders, and others. Based on distribution channel, Malaysia eye drop market is categorized into hospitals pharmacy, retail pharmacy, and online pharmacy. Based on region, the Malaysia eye drop market is segmented into the East Malaysia and West Malaysia.

Company Profiles

Alcon Laboratories (Malaysia) Sdn Bhd, Johnson & Johnson, CooperVision Contact Lens Malaysia Sdn Bhd, Metro optical Group Eyeware, TRB CHEMEDICA, Xepa Laboratories Pte. Ltd, Thea Pharma Sdn Bhd, Systane, and Rohto are some of the key players of Malaysia eye drop market.

Report Scope:

In this report, the Malaysia eye drop market has been segmented into the following categories, in addition to the industry trends, which have also been detailed below:

Malaysia Eye Drop Market, By Type:

  • Prescription
  • Over the Counter

Malaysia Eye Drop Market, By Drug Class:

  • Antiallergy
  • Anti-inflammatory
  • Antiglaucoma
  • Anti-VEGF
  • Others

Malaysia Eye Drop Market, By Disease Indication:

  • Dry Eye Diseases
  • Glaucoma
  • Eye Allergy
  • Eye Infections
  • Retinal Disorders
  • Others

Malaysia Eye Drop Market, By Distribution Channel:

  • Hospitals Pharmacy
  • Retail Pharmacy
  • Online Pharmacy

Malaysia Eye Drop Market, By Region:

  • The East Malaysia
  • The West Malaysia

Competitive landscape

Company Profiles: Detailed analysis of the major companies in Malaysia eye drop market.

Available Customizations:

With the given market data, the publisher offers customizations according to a company’s specific needs.


This product will be delivered within 1-3 business days.

Table of Contents

1. Product Overview
1.1. Market Definition
1.2. Scope of the Market
1.2.1. Markets Covered
1.2.2. Years Considered for Study
1.2.3. Key Market Segmentations
2. Research Methodology
2.1. Objective of the Study
2.2. Baseline Methodology
2.3. Key Industry Partners
2.4. Major Association and Secondary Sources
2.5. Forecasting Methodology
2.6. Data Triangulation & Validation
2.7. Assumptions and Limitations
3. Executive Summary
3.1. Overview of the Market
3.2. Overview of Key Market Segmentations
3.3. Overview of Key Market Players
3.4. Overview of Key Regions/Countries
3.5. Overview of Market Drivers, Challenges, Trends
4. Malaysia Eye Drop Market Outlook
4.1. Market Size & Forecast
4.1.1. By Value
4.2. Market Share & Forecast
4.2.1. By Type (Prescription v/s Over the Counter)
4.2.2. By Drug Class (Antiallergy, Anti-inflammatory, Antiglaucoma, Anti-VEGF, Others)
4.2.3. By Disease Indication (Dry Eye Diseases, Glaucoma, Eye Allergy, Eye Infections, Retinal Disorders, Others)
4.2.4. By Distribution Channel (Hospitals Pharmacy, Retail Pharmacy, Online Pharmacy)
4.2.5. By Region (East Malaysia, West Malaysia)
4.2.6. By Company (2022)
4.3. Product Market Map
5. Malaysia Prescription Eye Drop Market Outlook
5.1. Market Size & Forecast
5.1.1. By Value
5.2. Market Share & Forecast
5.2.1. By Drug Class
5.2.2. By Disease Indication
5.2.3. By Distribution Channel
6. Malaysia Over the Counter Eye Drop Market Outlook
6.1. Market Size & Forecast
6.1.1. By Value
6.2. Market Share & Forecast
6.2.1. By Drug Class
6.2.2. By Disease Indication
6.2.3. By Distribution Channel
7. Market Dynamics
7.1. Drivers
7.2. Challenges
8. Market Trends & Developments
8.1. Research & Development
8.2. Product launch
8.3. Merger & Acquisition
9. Policy and Regulatory Landscape10. Malaysia Eye Drop Market: SWOT Analysis11. Porter’s Five Forces Analysis12. PESTLE Analysis
13. Competitive Landscape
13.1. Business Overview
13.2. Product Offerings
13.3. Recent Developments
13.4. Financials (In Case of Listed Companies)
13.5. Key Personnel
13.6. Alcon Laboratories (Malaysia) Sdn Bhd
13.7. Johnson & Johnson
13.8. CooperVision Contact Lens Malaysia Sdn Bhd
13.9. Metro optical Group Eyeware
13.10. TRB CHEMEDICA
13.11. Xepa Laboratories Pte. Ltd
13.12. Thea Pharma Sdn Bhd
13.13. Systane
13.14. Rohto
14. Strategic Recommendations
About the Publisher & Disclaimer

Companies Mentioned (Partial List)

A selection of companies mentioned in this report includes, but is not limited to:

  • Alcon Laboratories (Malaysia) Sdn Bhd
  • Johnson & Johnson
  • CooperVision Contact Lens Malaysia Sdn Bhd
  • Metro optical Group Eyeware
  • TRB CHEMEDICA
  • Xepa Laboratories Pte. Ltd
  • Thea Pharma Sdn Bhd
  • Systane
  • Rohto